Fundraising Fox

Korro Bio

NASDAQ: KRRO

Cambridge, US · Founded 2018 · Delaware corporation · 2 known investors

RNA-editing therapeutics company using its OPERA technology platform.

Biotechin /korro-bio@korrobio

Founders & leadership

NB
Nessan BerminghamMr. Bermingham is the Executive Chair of the Issuer.
OC
Ommer ChohanMr. Chohan is the Secretary and Treasurer of the Issuer.
JF
Jean-Francois FormelaDirector

Investors · 2

Atlas VentureCambridge · $500K – $1Mvia Jean-François Formela · board
MC Healthcare VenturesCambridge

Reported raises · per SEC filings

Form D private placements
▶$4MraisedJun 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Nessan BerminghamExecutive Officer, Director, Promoter
  • Ommer ChohanExecutive Officer, Director, Promoter
  • Jean-Francois FormelaDirector
Offering amount
$4M
Amount sold
$4M
First sale
May 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.